reference/34809772

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34809772

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Randomized Controlled Trial\|Journal Article
endingPage	2118
issn	1068-9265 1534-4681
issueIdentifier	4
pageRange	2111-2118
publicationName	Annals of Surgical Oncology
startingPage	2111
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ba60c653ae5904fe2fa2b16794faf590 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b5a23f9032335801a64b5259a54650ba http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5325397d7d330787c50ed96798766875 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0ed1f1caf102785440515b48b48e1371 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f8236710ddec7aeba6b24ec817c797c7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_aefe92b31b1ebb86d3f02035a9f3b8e8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2b9f1f7ded9d26ac18ec7dc9585e7a44 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_340ba945f373934189331c876736ee0a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0d7ca35ded9cc7b8708f5d173bae49bc http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_769abf760ff0a582436316b9b63b9f7a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3037219a116f36f0e96c1e0aa6b15131 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_77ef90455e78c399b55f4bdc8f771bc1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2f2f58b4656d936311c1014b9af50e53 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f965c780245cdab417a9e253566d8eba http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f7fd88809cc5add36f08d443bae88f28 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8f96050c5628f19e155dc3eb5e36de48 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c3fb77161f34340f187e89622a77072b
bibliographicCitation	Hunt KK, Suman VJ, Wingate HF, Leitch AM, Unzeitig G, Boughey JC, Meric-Bernstam F, Ellis MJ, Olson J. Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. Ann Surg Oncol. 2023 Jan 18;30(4):2111–8. doi: 10.1245/s10434-022-12972-5.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac3e8a08478364a8a337937703a81afc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5793a2ddc0fd4649145c508846148fbc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd8f421771573ecd1131807f2de80dba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e178943ca50786dabd46cf1e0e86d73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbd3c8de7e30a2bc7267ac2e99ac256d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6af863fd3ce7b89a59a3555c80a394f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3e051c466cfcc1b469c24aed8d6910f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_485babe0843592a2703565281c099f74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67ae5f02f6e4edf5d60ee609492fbdc9
date	2023-01-18^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36653664 https://doi.org/10.1245/s10434-022-12972-5 https://pubmed.ncbi.nlm.nih.gov/PMC10373661
isPartOf	https://portal.issn.org/resource/ISSN/1534-4681 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8578 https://portal.issn.org/resource/ISSN/1068-9265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M000640349 http://id.nlm.nih.gov/mesh/M0158502 http://id.nlm.nih.gov/mesh/M0028859 http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0238999
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D001943Q000601 http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008408 http://id.nlm.nih.gov/mesh/D011960Q000032 http://id.nlm.nih.gov/mesh/D020360 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000077289Q000627 http://id.nlm.nih.gov/mesh/D017698 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D019394 http://id.nlm.nih.gov/mesh/D000077384Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2187 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902

Showing number of triples: 1 to 70 of 70.